Hyperkalaemic quadriparesis secondary to chronic diclofenac treatment

Postgraduate Medical Journal

Volumn 77, Issue 903, 2001, Pages 50-51

  Patel, P ^a   Mandal, B ^a   Greenway, M W ^a  

^a GLAN CLWYD HOSPITAL   (United Kingdom)

Author keywords

Diclofenac sodium; Drug induced hyperkalaemia; Hyperkalaemic paralysis

Indexed keywords

DICLOFENAC;

AGED; ARTICLE; CASE REPORT; DRUG EFFECT; FEMALE; GOUT; HUMAN; HYPERKALEMIA; IMMUNOSUPPRESSIVE TREATMENT; MUSCLE WEAKNESS; PERIODIC PARALYSIS; QUADRIPLEGIA;

AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DICLOFENAC; FEMALE; HUMANS; HYPERKALEMIA; QUADRIPLEGIA;

EID: 0035188014     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pmj.77.903.50     Document Type: Article

References (8)

1. Successful treatment of hyperkalaemic quadriplegia associated with spironolactone
2. Hyperkalemia associated with indomethacin
3. Hyperkalaemia in the elderly
4. Secondary hyperkalaemic paralysis
5. Hyperkalaemia in the elderly: Drugs exacerbate impaired potassium homeostasis
6. Hyperkalaemic metabolic acidosis
7. A mechanism for pentamidine-induced hyperkalemia: Inhibition of distal nephron sodium transport
8. Trimethoprim is a potassium-sparing diuretic like amiloride and causes hyperkalemia in high-risk patients